Obesity
Conditions
Brief summary
The safety and efficacy of the Adhesix Bioring adjustable gastric band will be assessed in patients after failed RYGB.
Interventions
DEVICEAdhesix Bioring
Sponsors
Archer Research
Duomed
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient must sign the informed consent form prior to the index-procedure. * Patient with failed RYGB defined as patients with EWL \<50%.
Exclusion criteria
* Patient has a life expectancy of less than 2 year. * Patient who is most likely expected not to be compliant with the proposed follow-up visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage excess weight loss | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Complications (perioperative, early and late) | 2 years |
| Mortality | 2 years |
| Technical success defined as laparoscopic implantation of the Adhesix Bioring as intended by the surgeon without conversion to open repair. | During procedure |
| BAROS score | 2 years |
| Frequency of revisions | 2 years |
| Regression of co-morbidities | 2 years |
Countries
Belgium
Outcome results
None listed